Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WeBET: Weight-Based Enoxaparin in Trauma
NCT01916707Phase 4Unknown
- Sponsor
- Intermountain Health
- Start
- Jul 2013
- Primary completion
- Jun 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of enoxaparin in venous thromboembolism (VTE), sponsored by Intermountain Health. Status: unknown.
02
Drugs
enoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT01916707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01916707.